Platelet abnormalities associated with cerebral perfusion defects in cocaine dependence

Biological Psychiatry

Volumn 55, Issue 1, 2004, Pages 91-97

  Kosten, Thomas R ^a,b   Tucker, Karen ^a,b   Gottschalk, P Christopher ^a,b   Rinder, Christine S ^a   Rinder, Henry M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Aspirin; Cerebral blood flow; Clinical trial; Cocaine; Neuroimaging; Platelet aggregation; Platelets; Single photon emission computed tomography (SPECT)

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CINGULATE GYRUS; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERFUSION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY;

EID: 0347683376     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00706-6     Document Type: Article

References (55)

1. Acton P.D., Friston K.J. Statistical parametric mapping in functional neuroimaging Beyond PET and fMRI activation studies . Eur J Nucl Med. 25:1998;663-667. [editorial].
2. Andersson J.L. How to estimate global activity independent of changes in local activity. Neuroimage. 6:1997;237-244.
3. Arndt S., Cizadlo T., O'Leary D., Gold S., Andreasen N.C. Normalizing counts and cerebral blood flow intensity in functional imaging studies of the human brain. Neuroimage. 3:1996;175-184.
4. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet. 348:1996;1329-1339.
5. Chamorro A., Escolar G., Revilla M., Obach V., Vila N., Reverter J.C., et al. Ex vivo response to aspirin differs in stroke patients with single or recurrent events A pilot study . J Neurol Sci. 171:1999;110-114.
6. Daras M., Tuchman A.J., Koppel B.S., Samkoff L.M., Weitzner I., Marc J. Neurovascular complications of cocaine. Acta Neurol Scand. 90:1994;124-129.
7. Davie A.P., Love M.P., McMurray J.J. Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure. Clin Pharmacol Ther. 67:2000;530-537.
8. Fein G., Di Sclafani V., Meyerhoff D.J. Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend. 68:2002;87-93.
9. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders. 2002;New York State Psychiatric Institute, New York.
10. Flores E.D., Lange R.A., Cigarroa R.G., Hillis L.D. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease Enhanced vasoconstriction at sites of significant stenoses . J Am Coll Cardiol. 16:1990;74-79.
11. Franklin T.R., Acton P.D., Maldjian J.A., Gray J.D., Croft J.R., Dackis C.A., et al. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry. 51:2002;134-142.
12. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis Neuroimaging evidence for the involvement of the frontal cortex . Am J Psychiatry. 159:2002;1642-1652.
13. Gottschalk P.C., Kosten T.R. Cerebral perfusion defects in combined cocaine and alcohol dependence. Drug Alcohol Depend. 68:2002;95-104.
14. Gottschalk P.C.H., Kosten T.R. Isradipine enhancement of cerebral blood flow in abstinent cocaine abusers with and without chronic perfusion deficits. Am J Addict. 11:2002;200-208.
15. Gullion C.M., Devous M.D. Sr, Rush A.J. Effects of four normalizing methods on data analytic results in functional brain imaging. Biol Psychiatry. 40:1996;1106-1121.
16. Gum P.A., Kottke-Marchant K., Poggio E.D., Gum H., Welsh P.A., Brooks L., et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol. 88:2001;230-235.
17. Gur R.C., Gur R.E., Resnick S.M., Skolnick B.E., Alavi A., Reivich M. The effect of anxiety on cortical cerebral blood flow and metabolism. J Cereb Blood Flow Metab. 7:1987;173-177.
18. Holman B.L., Carvalho P.A., Mendelson J., Teoh S.K., Nardin R., Hallgring E., et al. Brain perfusion is abnormal in cocaine-dependent polydrug users A study using technetium-99 m-HMPAO and ASPECT . J Nucl Med. 32:1991;1206-1210.
19. Holman B.L., Garada B., Johnson K.A., Mendelson J., Hallgring E., Teoh S.K., et al. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. J Nucl Med. 33:1992;1312-1315.
20. Holman B.L., Mendelson J., Garada B., Teoh S.K., Hallgring E., Johnson K.A., et al. Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users. J Nucl Med. 34:1993;723-727.
21. Holmes A.P. Statistical issues in functional brain mapping. 1993;University of Glasgow, Glasgow, Scotland.
22. Husain S., Andrews N.P., Mulcahy D., Panza J.A., Quyyumi A.A. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation. 97:1998;716-720. 239.
23. Imran M.B., Kawashima R., Sato K., Kinomura S., Ito H., Koyama M., et al. Mean regional cerebral blood flow images of normal subjects using technetium-99 m-HMPAO by automated image registration. J Nucl Med. 39:1998;203-207.
24. Jacobs I.G., Roszler M.H., Kelly J.K., Klein M.A., Kling G.A. Cocaine abuse Neurovascular complications . Radiology. 170:1989;223-227.
25. Karch S.B. Cocaine. Karch S.B. The Pathology of Drug Abuse. 1993;51-64 CRC Press, Boca Raton, FL.
26. Kosten T.R. Pharmacotherapy of cerebral ischemia in cocaine dependence. Drug Alcohol Depend. 49:1998;133-144.
27. Kosten T.R., Cheeves C., Palumbo J., Seibyl J.P., Price L.H., Woods S.W. Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse. Drug Alcohol Depend. 50:1998;187-195.
28. Kosten TR, Gottschalk PC, Tucker K, Rinder CS, Dey H, Rinder HM (in press-b): Aspirin or amiloride for cerebral perfusion defects in cocaine dependence. Drug Alcohol Depend.
29. Kosten TR, Scanley BE, Tucker K, Prince C, Sinha R, Potenza MN, et al (in press-a) Cue-induced brain activity changes and treatment outcome in depressed cocaine dependent patients. Am J Psychiatry.
30. Kugelmass A.D., Oda A., Monahan K., Cabral C., Ware J.A. Activation of human platelets by cocaine. Circulation. 88:1993;876-883.
31. Levine S.P., Towell B.L., Suarez A.M., Knieriem L.K., Harris M.M., George J.N. Platelet activation and secretion associated with emotional stress. Circulation. 71:1985;1129-1134.
32. Levine S.R., Brust J.C., Futrell N., Ho K.L., Blake D., Millikan C.H., et al. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med. 323:1990;699-704. [comment].
33. Logigian E.L., Johnson K.A., Kijewski M.F., Kaplan R.F., Becker J.A., Jones K.J., et al. Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology. 49:1997;1661-1670.
34. Madden J.A., Konkol R.J., Keller P.A., Alvarez T.A. Cocaine and benzoylecgonine constrict cerebral arteries by different mechanisms. Life Sci. 56:1995;679-686.
35. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 168:1980;26-33.
36. Mena I., Giombetti R.J., Cody C.K. Acute cerebral blood flow changes with cocaine intoxication. Neurology. 40:1990;179. [abstract].
37. Noe D.A., Kumor K.M. A pharmacokinetic-pharmacodynamic model of heart rate during cocaine administration in humans. Clin Pharmacol Ther. 49:1991;426-432.
38. Rezkallah S., Mazza J.J., Kloner R.A., Pilemma V., Chang S.H. The effect of cocaine on human platelets. J Am Coll Cardiol. 19:1992;322A.
39. Rinder C.S., Student L.A., Bonan J.L., Rinder H.M., Smith B.R. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood. 82:1993;505-512.
40. Rinder H.M., Ault K.A., Jatlow P.I., Kosten T.R., Smith B.R. Platelet alpha-granule release in cocaine users. Circulation. 90:1994;1162-1167.
41. Rinder H.M., Bonan J.L., Rinder C.S., Ault K.A., Smith B.R. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood. 78:1991;1760-1769.
42. Saady J.J., Bowman E.R., Aceto M.D. Cocaine, ecgonine methyl ester, and benzoylecgonine plasma profiles in rhesus monkeys. J Anal Toxicol. 19:1995;571-575.
43. Schror K. Aspirin and platelets The antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis . Semin Thromb Hemost. 23:1997;349-356.
44. Stamatakis E.A., Glabus M.F., Wyper D.J., Barnes A., Wilson J.T. Validation of statistical parametric mapping (SPM) in assessing cerebral lesions A simulation study . Neuroimage. 10:1999;397-407.
45. Strickland T.L., Mena I., Villanueva-Meyer J., Miller B.L., Cummings J., Mehringer C.M., et al. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci. 5:1993;419-427.
46. Tofler G.H., Brezinski D., Schafer A.I., Czeisler C.A., Rutherford J.D., Willich S.N., et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med. 316:1987;1514-1518.
47. Togna G., Tempesta E., Togna A.R., Dolci N., Cebo B., Caprino L. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment. Haemostasis. 15:1985;100-107.
48. Tumeh S.S., Nagel J.S., English R.J., Moore M., Holman B.L. Cerebral abnormalities in cocaine abusers Demonstration by SPECT perfusion brain scintigraphy. Work in progress . Radiology. 176:1990;821-824.
49. Vitullo J.C., Karam R., Mekhail N., Wicker P., Engelmann G.L., Khairallah P.A. Cocaine-induced small vessel spasm in isolated rat hearts. Am J Pathol. 135:1989;85-91.
50. Volkow N.D., Hitzemann R., Wang G.J., Fowler J.S., Wolf A.P., Dewey S.L., et al. Long-term frontal brain metabolic changes in cocaine abusers. [published erratum appears in Synapse 1992;12:86] Synapse. 11:1992;184-190.
51. Volkow N.D., Mullani N., Gould K.L., Adler S., Krajewski K. Cerebral blood flow in chronic cocaine users A study with positron emission tomography . Br J Psychiatry. 152:1988;641-648.
52. Weber D.A., Franceschi D., Ivanovic M., Atkins H.L., Cabahug C., Wong C.T., et al. SPECT and planar brain imaging in crack abuse Iodine-123- iodoamphetamine uptake and localization . J Nucl Med. 34:1993;899-907.
53. Woods R.P., Grafton S.T., Holmes C.J., Cherry S.R., Mazziotta J.C. Automated image registration I. General methods and intrasubject, intramodality validation . J Comput Assist Tomogr. 22:1998;139-152.
54. Worsley K.J., Poline J.B., Vandal A.C., Friston K.J. Tests for distributed, nonfocal brain activations. Neuroimage. 2:1995;183-194.
55. Yang L.H., Fareed J. Vasomodulatory action of clopidogrel and ticlopidine. Thromb Res. 86:1997;479-491.